Abstract
Aim: To assess the effect of a lifestyle-based prostate cancer pathway, incorporated in daily practice, to increase the implementation of evidence-based strategies to manage ADT-induced side effects. Methods: PCa patients receiving ADT for >6 months were referred to the pathway (ie as standard practice), through a central coordinator. The pathway consisted of a medical screening (ie bone and cardiometabolic screening) and a rehabilitation program with a supervised exercise program (3 months) and referrals to a dietician and a psychologist. Anthropometric parameters and physical performance were measured at baseline and after 3 months. Primary endpoint was physical performance evaluated with the 400-m walk test. Planned referral target was set at 200 to accomplish a sample size of 120 patients following the exercise program. A meaningful clinically important difference of the 400-m testwas defined as 17 s improvement and P < .05 was considered statistically significant. Results: Between January 2015 and June 2018, 200 patients were referred to the pathway, of which 177 were enrolled (median age 69, IQR 63-74). The majority (84%) had a good functional status (Karnofsky Performance ≥90) at baseline. The indication for ADT was curative in combination with local therapy for locally advanced PCa in 67% and palliative for (non)metastatic PCa in 33% of patients. In total, 124 followed the complete pathway. Medical screening indicated a lower bone mineral density in 51% of the patients and 25% had metabolic syndrome. After initial referral, 43% choose to receive diet advice and 64% psycho-education. A clinically meaningful performance improvement was observed in patients following the exercise program (282 to 253 s; P < .001). Compliance rate of the exercise program was high (83%). A total of 10% dropped-out due to medical reasons. After the 3-month exercise program, 81% voluntary continued. Conclusion: Physical performance improved after following a lifestylebased clinical pathway for prostate cancer patients in daily practice.
| Original language | English |
|---|---|
| Number of pages | 2 |
| Journal | Asia-Pacific Journal of Clinical Oncology |
| Volume | 15 |
| Issue number | SUPPL 9 |
| DOIs | |
| Publication status | Published - 2019 |
| Externally published | Yes |
Bibliographical note
M1 - (Bultijnck R.; Rammant E.; Fonteyne V.; Decastecker K.; Lumen N.; Ost P.) Department of Human Structure and Repair, Ghent University, Ghent, BelgiumM1 - (Bultijnck R.; Ost P.) Research Foundation - Flanders (FWO), Brussels, Belgium
M1 - (Bruggeman A.; Van Ruymbeke B.; De Muynck M.) Department of Physical and Rehabilitation Medicine, Ghent University Hospital, Ghent, Belgium
M1 - (Mortier S.; Raes A.) Cancer Center, Ghent University Hospital, Ghent, Belgium
M1 - (Deforche B.) Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
M1 - (Deforche B.) Department of Physical Activity, Nutrition and Health, Vrije Universiteit Brussel, Brussels, Belgium
Keywords
- advanced cancer
- aged
- androgen deprivation therapy
- anthropometric parameters
- bone density
- cancer patient
- clinical practice
- conference abstract
- controlled study
- diet
- dietitian
- exercise
- functional status
- human
- human tissue
- lifestyle
- local therapy
- major clinical study
- male
- metabolic syndrome X
- patient referral
- physical performance
- prostate cancer
- psychoeducation
- psychologist
- rehabilitation
- sample size
- side effect
- walk test